• Phare
  • Validé par KD/KO

Anticorps Polyclonal de lapin anti-DRD2

DRD2 Polyclonal Antibody for WB, IF-P, IF-Fro, IP, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, souris et plus (1)

Applications

WB, IHC, IF-P, IF-Fro, IP, ELISA

Conjugaison

Non conjugué

Publications(46)

N° de cat : 55084-1-AP

Synonymes

D(2) dopamine receptor, D2 dopamine receptor, D2DR, D2R, Dopamine D2 receptor



Applications testées

Résultats positifs en WBcellules HEK-293, cellules SH-SY5Y, tissu cérébral de rat, tissu cérébral de souris
Résultats positifs en IPcellules SH-SY5Y,
Résultats positifs en IF-Ptissu cérébral de souris,
Résultats positifs en IF-Frotissu cérébral de souris,

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:4000
Immunoprécipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunofluorescence (IF)-PIF-P : 1:50-1:500
Immunofluorescence (IF)-FROIF-FRO : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

55084-1-AP cible DRD2 dans les applications de WB, IHC, IF-P, IF-Fro, IP, ELISA et montre une réactivité avec des échantillons Humain, souris

Réactivité Humain, souris
Réactivité citéerat, Humain, souris
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène Peptide
Nom complet dopamine receptor D2
Masse moléculaire calculée 51 kDa
Poids moléculaire observé50-60 kDa
Numéro d’acquisition GenBankNM_016574
Symbole du gène DRD2
Identification du gène (NCBI) 1813
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

DRD2, also named D2DR and D2R, belongs to the G-protein coupled receptor 1 family. It is one of the five types (D1 to D5) of receptors for dopamine. The activity of DRD2 is mediated by G proteins which inhibit adenylyl cyclase. Defects in DRD2 are associated with dystonia type 11 (DYT11). The antibody is specific to DRD2.

Protocole

Product Specific Protocols
WB protocol for DRD2 antibody 55084-1-APDownload protocol
IF protocol for DRD2 antibody 55084-1-APDownload protocol
IP protocol for DRD2 antibody 55084-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Cell

PMID: 25594175

Authors - Yiqing Yan
  • KD Validated
rat

Nat Commun

Non-canonical interplay between glutamatergic NMDA and dopamine receptors shapes synaptogenesis

Authors - Nathan Bénac
mouseWB

Mol Psychiatry

ZFP804A mutant mice display sex-dependent schizophrenia-like behaviors.

Authors - Ying Huang
ratWB

J Affect Disord

Pramipexole improves depression-like behavior in diabetes mellitus with depression rats by inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing impaired neuroplasticity

Authors - Ping Li
ratWB

Int J Mol Sci

Biochemical Neuroadaptations in the Rat Striatal Dopaminergic System after Prolonged Exposure to Methamphetamine Self-Administration

Authors - Subramaniam Jayanthi
mouseWB

J Neuroimmune Pharmacol

5-HT4 Receptor is Protective for MPTP-induced Parkinson's Disease Mice Via Altering Gastrointestinal Motility or Gut Microbiota

Authors - Chun Cui

Avis

The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.


FH

ARUNASALAM (Verified Customer) (05-29-2025)

This antibody worked for western blotting.

  • Applications: Western Blot
  • Cell Tissue Type: Human Cancer Cell Lines
FH

Ping (Verified Customer) (06-04-2019)

This antibody is good for both immunoprecipitation and western blot.

  • Applications: Western Blot, Immunoprecipitation,
  • Primary Antibody Dilution: 1:500
  • Cell Tissue Type: rat brain tissue
{{ptg:RelatedPrimaryAntibodies}}